The usefulness and the limitations of animal models in identifying targets for therapy in arthritis

Paul H Wooley1

  • 1Department of Orthopaedic Surgery, Wayne State University School of Medicine, 1 South, Hutzel Hospital, 4707 St. Antonie Blvd, Detroit, MI 48201, USA. pwooley@wayne.edu

Insights

Animal models are crucial for developing rheumatoid arthritis (RA) therapies. Studying models like collagen-induced arthritis advanced cytokine inhibitor treatments for RA.

Area of Science:

  • Rheumatology and immunology
  • Pharmacology and drug discovery
  • Translational medicine

Background:

  • Animal models have been instrumental in advancing rheumatoid arthritis (RA) drug development.
  • Understanding connective tissue disease mechanisms often relies on animal model studies.
  • These models identify potential therapeutic targets for RA treatment.

Purpose of the Study:

  • To review the historical contributions of animal models in rheumatoid arthritis therapy.
  • To highlight the link between animal model findings and novel therapeutic strategies.
  • To examine the role of specific models, like collagen-induced arthritis, in RA treatment advancements.

Main Methods:

  • Review of historical data and scientific literature on animal models in arthritis research.
  • Analysis of the progression of arthritis therapies from early models to advanced biologicals.
  • Focus on the development of cytokine inhibitors stemming from rodent arthritis models.

Main Results:

  • Adjuvant arthritis and COX-1 inhibitors represent early contributions of animal models.
  • Transgenic mice and biological response modifiers showcase later advancements.
  • Collagen-induced arthritis in rodents was pivotal for developing cytokine inhibitors for RA.

Conclusions:

  • Animal models are indispensable for understanding RA pathology and developing new treatments.
  • The study of animal models directly informs the identification and evaluation of therapeutic targets.
  • Insights from collagen-induced arthritis models have led to successful RA therapies, particularly cytokine inhibitors.

Related Concept Videos